HomeBLPH • OTCMKTS
add
Bellerophon Therapeutics Inc
Previous close
$0.036
Day range
$0.036 - $0.036
Year range
$0.029 - $0.42
Market cap
396.34K USD
Avg Volume
3.84K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.17M | -57.58% |
Net income | -1.92M | 62.10% |
Net profit margin | — | — |
Earnings per share | -0.17 | 68.21% |
EBITDA | -2.17M | 57.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.38M | -61.28% |
Total assets | 4.98M | -60.51% |
Total liabilities | 1.26M | -75.75% |
Total equity | 3.72M | — |
Shares outstanding | 12.23M | — |
Price to book | 0.12 | — |
Return on assets | -66.88% | — |
Return on capital | -116.09% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -1.92M | 62.10% |
Cash from operations | -6.33M | -26.39% |
Cash from investing | 140.00K | — |
Cash from financing | 0.00 | — |
Net change in cash | -6.19M | -23.59% |
Free cash flow | -5.63M | -80.31% |
About
Founded
2009
Headquarters
Website
Employees
18
